Definición de «Natalizumab»

Las siguientes páginas tratan de la palabra 'Natalizumab'

/transcripciones/
avances_e

Más información sobre 'Natalizumab'

Leer sobre la tema 'Natalizumab' en digg.com

Natalizumab reduces MS relapses and disability--Cochrane review | TheMedGuru

tópico: Lifestyle

Dr Doug Brown, Head of Biomedical Research at theMS Society, said, "Natalizumab is a licensed treatment for MS in the UK and we have known for some time that it reduces relapse rates and progression of disability in people with relapsing remitting MS; it’s nice to see these findings confirmed in this review.”

New Data Alter Natalizumab Safety Considerations in MS - MedConnect India

tópico: Lifestyle

HONOLULU (EGMN) – Results of five diverse studies on the risk of progressive multifocal leukoencephalopathy when using natalizumab to treat multiple sclerosis could change the way clinicians decide how to manage these patients.

New Risk Factor Identified for PML With Natalizumab - MedConnect India

tópico: Science

The U.S. Food and Drug Administration has identified a new risk factor for progressive multifocal leukoencephalopathy, a life-threatening brain infection associated with the use of natalizumab, an immunomodulatory agent used to treat multiple sclerosis and Crohn’s disease.

FDA Drug Safety Communication: Safety update on Progressive Multifocal Leukoencephalopathy (PML) associated with Tysabri (natalizumab)

tópico: Lifestyle

[04-22-2011] The U.S. Food and Drug Administration (FDA) continues to evaluate the risk of progressive multifocal leukoencephalopathy (PML), a rare but serious brain infection, associated with use of Tysabri (natalizumab) for the treatment of multiple sclerosis (MS) and Crohn's disease.

Sclerosi Multipla: sospendere il trattamento con natalizumab può aumentare il rischio di Sindrome Infiammatoria da Ricostituzione Immunitaria? - Ultime notizie - Sclerosi multipla - Fondazione Cesare Serono

tópico: Lifestyle

In uno studio condotto da un gruppo di ricercatori di diversi stati, e pubblicato sulla rivista Archives of Neurology, alcuni dei pazienti che avevano sospeso il trattamento con natalizumab hanno sviluppato la Sindrome Infiammatoria da Ricostituzione Immunitaria (IRIS).

Natalizumab Has Minimal Effect on Response to Vaccines - MedConnect India

tópico: Lifestyle

HONOLULU (EGMN) –Patients taking natalizumab showed similar or only slightly delayed humoral immune responses following vaccinations, compared with patients not taking the drug for relapsing-remitting multiple sclerosis in a multicenter, randomized, open-label study.

Tysabri/natalizumab for pediatric multiple sclerosis study results

tópico: World News

It is estimated about 8,000 to 10,000 children (those who are up to the age of 18) have multiple sclerosis (MS), with 5% of the total number being younger than

New data gives positive safety profile for Tysabri (natalizumab)

tópico:

Tysabri was withdrawn in February 2005 after two deaths because of PML . The Biogen Idec announced that no new cases of a PML (progressive multifocal leukoencephalopathy ) have been reported among patients taking Biogen Idec's multiple sclerosis drug Tysabri, since the FDA allowed it back into the market.

If caught early, Natalizumab-PML not fatal for MS patients

tópico: Lifestyle

The newest research is showing that, caught early, PML doesn't have to be as much of a worry as it has been. "We used to think PML was always fatal, but now we are learning that it might not always be," says Kate Weiss, a spokesperson for Biogen, Inc., the makers of natalizumab.

Twitters sobre Natalizumab

Risk stratification and patient counseling for natalizumab in multiple sclerosis http://t.co/CtdeBhj6

2012-02-06T21:57:47Z

FDA - PML=rare but serious brain infection assoc with use of Tysabri (natalizumab) 4 treatment of MS or Crohn's disease http://t.co/ta2J8IIp

2012-02-06T18:11:16Z

#ms: Tysabri (Natalizumab) - http://t.co/SJnZD65W http://t.co/wS55qeHx

2012-02-05T09:39:32Z

Natalizumab-associated progressive multifocal leucoencephalopathy: a practical approach to risk profiling and monitoring.

2012-02-04T11:08:00Z

ASCEND Study to Evaluate the Effectiveness of TYSABRI® (natalizumab) as a Treatment for Secondary-Progressive Multiple ...

2012-02-04T10:03:27Z

Information on Natalizumab (marketed as Tysabri) http://t.co/JUICg4pL

2012-02-04T01:32:56Z

Natalizumab treatment of multiple sclerosis in Spain: results of an extensive observational study http://t.co/Ueqt1B54

2012-02-03T20:12:28Z

FDA New risk factor for Progressive Multifocal Leukoencephalopathy (#PML) associated with #Tysabri (#natalizumab)http://t.co/JiBMZ4dR

2012-02-03T17:54:19Z

RT @mrdphd: Hellwig K et al., Immune reconstitution Inflammatory syundrome in natalizumab-associated PML. Editor’s choice. Neurology, 2012 January 31

2012-02-03T17:23:21Z

Hellwig K et al., Immune reconstitution Inflammatory syundrome in natalizumab-associated PML. Editor’s choice. Neurology, 2012 January 31

2012-02-03T16:12:20Z